Literature DB >> 15489508

The enzymatic activities of the Werner syndrome protein are disabled by the amino acid polymorphism R834C.

Ashwini S Kamath-Loeb1, Piri Welcsh, Maureen Waite, Elinor T Adman, Lawrence A Loeb.   

Abstract

The Werner syndrome protein, WRN, is a member of the RecQ family of DNA helicases. It possesses both 3'-->5' DNA helicase and 3'-->5' DNA exonuclease activities. Mutations in WRN are causally associated with a rare, recessive disorder, Werner syndrome (WS), distinguished by premature aging and genomic instability; all are reported to result in loss of protein expression. In addition to WS-linked mutations, single nucleotide polymorphisms, with frequencies that exceed those of WS-associated mutations, are also present in WRN. We have initiated studies to determine if six of these polymorphisms affect the enzymatic activities of WRN. We show that two common polymorphisms, F1074L and C1367R, and two infrequent polymorphisms, Q724L and S1079L, exhibit little change in activity relative to wild-type WRN; the polymorphism, T172P, shows a small but consistent reduction of activity. However, an infrequent polymorphism, R834C, located in the helicase domain dramatically reduces WRN helicase and helicase-coupled exonuclease activity. The structure of the E. coli helicase core suggests that R834 may be involved in interactions with ATP. As predicted, substitution of Arg with Cys interferes with ATP hydrolysis that is absolutely required for unwinding DNA. R834C thus represents the first missense amino acid polymorphism in WRN that nearly abolishes enzymatic activity while leaving expression largely unaffected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489508     DOI: 10.1074/jbc.M407128200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

2.  Delineation of WRN helicase function with EXO1 in the replicational stress response.

Authors:  Monika Aggarwal; Joshua A Sommers; Christa Morris; Robert M Brosh
Journal:  DNA Repair (Amst)       Date:  2010-05-05

3.  Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.

Authors:  Min Shen; Tongzhang Zheng; Qing Lan; Yawei Zhang; Shelia H Zahm; Sophia S Wang; Theodore R Holford; Brian Leaderer; Meredith Yeager; Robert Welch; Daehee Kang; Peter Boyle; Bing Zhang; Kaiyong Zou; Yong Zhu; Stephen Chanock; Nathaniel Rothman
Journal:  Hum Genet       Date:  2006-04-26       Impact factor: 4.132

Review 4.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

5.  The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.

Authors:  Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathleen Hennessy; Gary L Rosner; Edwin Cook; M Eileen Dolan; Mark J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  2008-08-02       Impact factor: 3.333

Review 6.  WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects.

Authors:  Koutaro Yokote; Sirisak Chanprasert; Lin Lee; Katharina Eirich; Minoru Takemoto; Aki Watanabe; Naoko Koizumi; Davor Lessel; Takayasu Mori; Fuki M Hisama; Paula D Ladd; Brad Angle; Hagit Baris; Kivanc Cefle; Sukru Palanduz; Sukru Ozturk; Antoinette Chateau; Kentaro Deguchi; T K M Easwar; Antonio Federico; Amy Fox; Theresa A Grebe; Beverly Hay; Sheela Nampoothiri; Karen Seiter; Elizabeth Streeten; Raul E Piña-Aguilar; Gemma Poke; Martin Poot; Renata Posmyk; George M Martin; Christian Kubisch; Detlev Schindler; Junko Oshima
Journal:  Hum Mutat       Date:  2016-10-07       Impact factor: 4.878

7.  Functional deficit associated with a missense Werner syndrome mutation.

Authors:  Takashi Tadokoro; Ivana Rybanska-Spaeder; Tomasz Kulikowicz; Lale Dawut; Junko Oshima; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2013-04-11

Review 8.  The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.

Authors:  Meltem Muftuoglu; Junko Oshima; Cayetano von Kobbe; Wen-Hsing Cheng; Dru F Leistritz; Vilhelm A Bohr
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

9.  WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil.

Authors:  Giovanny R Pinto; France K N Yoshioka; Carlos A Clara; Marcelo J Santos; José R W Almeida; Rommel R Burbano; Juan A Rey; Cacilda Casartelli
Journal:  J Neurooncol       Date:  2008-08-01       Impact factor: 4.130

10.  WRN helicase defective in the premature aging disorder Werner syndrome genetically interacts with topoisomerase 3 and restores the top3 slow growth phenotype of sgs1 top3.

Authors:  Monika Aggarwal; Robert M Brosh
Journal:  Aging (Albany NY)       Date:  2009-02-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.